Iontronic Tech Promises Hope in Slowing Malignant Brain Tumors by Lilu Anderson 20.06.2024 "Iontronic tech shows promise in slowing malignant brain tumor growth by continuously delivering low-dose drugs, bypassing the blood-brain barrier."
Biotech’s Big Gamble Fails: Insights and Implications by Lilu Anderson 18.06.2024 Catch up on biotech headlines: Zentalis faces FDA hold, Aerovate's major setback, Merck's new vaccine, and promising trials by Intra-Cellular ...
Biotech’s Big Gamble Fails: Insights and Implications by Lilu Anderson 18.06.2024 Catch up on biotech headlines: Zentalis faces FDA hold, Aerovate's major setback, Merck's new vaccine, and promising trials by Intra-Cellular ...
CDS Analytical Licenses UD’s Game-Changing Proteomics Tech by Lilu Anderson 16.06.2024 E3technology enhances Empore™ membranes for better proteome sample prep, crucial for low-cell proteomics, say experts at UD and CDS Analytical.
Winnipeg Biotech Company’s Breakthrough in Phage Therapy by Lilu Anderson 28.03.2024 Phage therapy, unlocking the potential of bacteria phages, is being used to treat antibiotic-resistant infections. It potentially saved a woman's ...
NextCure, Inc.: Promising Growth Potential or Risky Investment? by Mark Eisenberg 28.03.2024 NextCure, Inc. (NXTC) is a biopharmaceutical company focused on novel immunomedicines. Strong financials, positive outlook, and promising pipeline.
Cellebrite Stock Upgraded by BofA: Buy Now! by Mark Eisenberg 16.02.2024 Bank of America Securities upgrades Cellebrite stock to Buy, increasing price target to $12. Improved business momentum and strong market ...
Connect Biopharma Welcomes James Huang: Growth Surge Ahead by Mark Eisenberg 13.02.2024 Connect Biopharma has appointed James Zuie-chin Huang to its Board of Directors. Huang brings over 30 years of biotech experience ...
Anixa’s Ovarian Cancer Trial Progress: Promising Results by Terry Bingman 12.02.2024 Anixa Biosciences advances Phase 1 clinical trial for ovarian cancer therapy, increasing dosage and showing promising results. Market responds positively ...